Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Jan Woitas/picture alliance via Getty Images

Scientists say accelerating deforestation could lead to increased human contact with pandemic diseases, and could also worsen the current coronavirus pandemic, NPR reports.

What's happening: Money and resources for monitoring tropical forests in Southeast Asia, Africa and South America have been transferred to help fight the pandemic, turning a blind eye toward illegal deforestation activities like logging and mining.

  • “There are several pathogens that once you have a deforestation event then you get spillover and you don’t know whether that’s because we’re losing biodiversity that otherwise would kind of help dilute that pathogen, or if it's humans coming into the area and increasing their risky behaviors," Christina Faust, postdoctoral scholar Center for Infectious Disease Dynamics at Penn State University, told NPR.

The bottom line: Researchers believe 75% of all emerging infectious diseases are zoonotic. Eliminating ecosystems means emerging pathogens have fewer and fewer non-humans to infect.

Go deeper

Oct 1, 2020 - Health

New poll shows alarming coronavirus vaccine skepticism

Illustration: Eniola Odetunde/Axios

 Lack of trust in a potential coronavirus vaccine is becoming a truly major problem, according to a new Stat/Harris Poll survey shared with Axios.

By the numbers: 79% of respondents said they would worry about a vaccine's safety if it's approved quickly, and 75% said they worry about politics — rather than science — driving the process.

Stocks slide after Trump tests positive for coronavirus

Illustration: Aïda Amer/Axios

U.S. stocks opened lower on Friday morning, following news early on Friday that President Trump and first lady Melania Trump tested positive for the coronavirus.

By the numbers: The S&P 500 fell 1%, the Dow Jones Industrial Average dropped 400 points (or 1.6%), while the Nasdaq Composite fell 1.5%. The declines

Oct 1, 2020 - Health

Pfizer CEO: COVID-19 vaccine development is "moving at the speed of science"

Pfizer CEO Albert Bourl speaking in New York City in 2019. Photo: Steven Ferdman/Getty Images

Pfizer CEO Albert Bourla told employees in a letter Thursday that he is disappointed his company's coronavirus vaccine was politicized during this week’s presidential debate, adding that campaign rhetoric about the outbreak and vaccine development is “undercutting public confidence," according to AP and CNBC.

Why it matters: President Trump accused pharmaceutical companies of slowing their COVID-19 vaccine development to hurt him politically at Tuesday's debate, claiming the U.S. is "weeks away from a vaccine," per Stat News.